At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. It's now my pleasure to turn the call over to David Sigmon, Greenlight Capital Re, Ltd.'s General Counsel. You may begin.

Thank you, and good morning. I would like to remind you that this conference call is being recorded and will be available for replay following the conclusion of the event. An audio replay will also be available under the Investors section of the company's website at www.greenlightre.com. Joining us on the call today will be our Chief Executive Officer, Greg Richardson, Chairman of the Board, David Einhorn, and Chief Financial Officer, Faramarz Romer. On behalf of the company, I'd like to remind you that forward-looking statements may be made during this call and are intended to be covered by the Safe Harbor provisions of the federal securities laws. These forward-looking statements reflect the company's current expectations, estimates, and predictions about future results and are subject to risks and uncertainties. As a result, actual results may differ materially from those expressed or implied. For more information on the risks and other factors that may impact future performance, investors should review the periodic reports that are filed by the company with the SEC from time to time. Additionally, management may refer to certain non-GAAP financial measures. The reconciliations to these measures can be found in the company's filings with the SEC, including the company's recently filed Form 10-K for the year ended December 31, 2024. The company undertakes no obligation to publicly update or revise any forward-looking statements. With that, it is now my pleasure to turn the call over to Greg.

Thanks, David. Good morning, everyone, and thank you for joining us today. To start off, I would like to thank everyone that attended our Investor Day presentation in New York City last November, where we provided additional color on Greenlight Capital Re, Ltd.'s progress and our go-forward strategy. I'm excited about Greenlight Capital Re, Ltd.'s future notwithstanding the fourth quarter results. The fourth quarter of 2024 was challenging for Greenlight Capital Re, Ltd. We reported a net underwriting loss of $18 million or a combined ratio of 112.1%. An investment loss from Solace Glass of $8.8 million or negative 1.9% driving a net loss for the quarter of $27.4 million of cat activity in the quarter and prior year development. On the cat side, we booked $17.6 million of cat losses in quarter four 2024, with Hurricane Milton being the most material at $7.5 million. With regard to prior year development, the major driver was a $15 million increase in our Russia-Ukraine conflict reserves linked to the confiscation of aircraft. We booked an initial provision for the Russia-Ukraine conflict in the first quarter of 2022, and that provision remained broadly flat over the intervening quarters. However, in Q4 of last year, following the commencement of high court litigation in London, we became aware of increased settlement activity. Based on our analysis of various legal claims and industry sources, and in anticipation of formal claim notifications, we decided to get ahead of this issue and to strengthen our IDNR provision. Our fourth quarter turned our solid performance for the first three quarters of the year into an underwriting loss of $8.2 million or a combined ratio of 101.4% for the full year 2024. Net income for the year was $42.8 million, which generated a 7.2% increase in fully diluted book value…

Thanks, Greg, and good morning, everyone. The Solus Glass Fund returned negative 1.9% in the fourth quarter. Our long portfolio detracted 3% on a gross basis, while the short and macro portfolios contributed 1.2% and 0.1% respectively. During the quarter, the S&P 500 index advanced 2.4%. The largest positive contributors were long investments in Peloton Interactive and Kyndra Holdings and a newly established arbitrage position in MicroStrategy. The largest detractors were long investments in Greenberg Partners and Solvay, and a short position in a profitless technology company. Peloton Interactive advanced 86% during the quarter. With this quarterly update, the company demonstrated progress in its cost-cutting initiatives and reaffirmed its commitment to prioritizing profitability. Peloton also announced the hiring of a well-regarded CEO who began his tenure with the company around the beginning of the year. Kyndra Holdings advanced 51% during the quarter. Its most recent quarterly update, Kyndryl announced another set of positive results, raised its guidance, and showed significant improvement in signings. The company also reaffirmed its positive fiscal 2025 outlook with constant currency revenues now expected to return to growth by the fiscal fourth quarter and margins set to again improve. Our new position shorting levered ETFs that aim to double the daily return of MicroStrategy stock, which is partially offset by owning MicroStrategy stock, was our third largest positive contributor. Greenberg shares fell over 32% over the quarter, giving back most of the gains from the third quarter as rising interest rates weighed on the sector. In November, we increased the size of our short basket of homebuilder stocks, which enabled us to offset about half of Green Brick's negative contribution for the quarter. Solvay declined 12% over the quarter. The company announced quarterly results that mostly met expectations but allowed for skeptics to debate the quality…

Thank you, David. Good morning, everyone. During the fourth quarter of 2024, Greenlight Capital Re, Ltd. reported a net loss of $27.4 million or a loss of $0.81 per diluted share compared to net income of $17.6 million or $0.50 per diluted share during the fourth quarter of 2023. The underwriting loss of $18 million translated into a combined ratio of 112.1%. Fourth quarter cat losses added 11.9 percentage points to our combined ratio, while the aviation reserves strengthening relating to the Russia-Ukraine conflict contributed 10.1 percentage points of combined ratio. As Greg mentioned, we have revised our segment disclosures to present our results separately for the open market segment and the innovation segment. For each of these segments, we now present the underwriting results and any investment income that is directly attributable to those segments. For the open market segment, the investment income includes interest income on the collateral we have pledged through our open market seedings, and any interest and investment income related to our funds at Lloyds business. For our innovation segment, the investment income includes interest on the collateral pledged to the innovation seedants, and any investment gains or losses from our private innovations investments. We also allocate corporate and other expenses such as personnel costs and other overhead expenses that can be attributable to the innovations, investments, operations. Any other income or expense that is not attributable to the two segments is included as corporate. As we have mentioned on previous calls, we non-renewed and placed into runoff the sole innovations property program due to the impact of underlying exposure to severe convective storms. That runoff business is also included under corporate. We believe the new segment reporting structure provides greater transparency and insight into the performance of our in-force business and aligns with how…

Thank you. And I'll be conducting a question and answer session. If you'd like to be placed in the question queue, please press. You may press star two before pressing star keys. One moment please while we poll for questions. Our first question today is coming from Anthony Motelisi from Dowling Partners. Your line is now live.

Hi. Good morning. Greg, do you think you could share some more information on that Q4 charge related to Russia, Ukraine? Maybe help frame it in the sense of how does this fit into your view on the ultimate industry loss? Really any additional insight in potential losses to Greenlight Capital Re, Ltd. would be helpful here. Thank you.

Oh, sure. Morning, Anthony. Thanks for the question. I'll start and then Faramarz can add color to it. The thrust of your question is how do we view this in terms of ultimate losses. With all of our losses, we endeavor to book what we think are the ultimate loss ratios for all the contracts in every line of business. That's our goal. So this is not intended to be a down payment on what we think the ultimate loss is. This is what we think the ultimate loss is. Obviously, there's some uncertainty but perhaps not as much as one might think. Already, there's been some settlements, significant settlements in the industry. There's been significant legal expenses. And then there's a limited bounded number of aircraft involved at the end of the day. So that limits the range. In addition, we have outward retrocession. So we're booking a number which is net of that. And that retrocession will cover is not exhaust. We're into it, but not exhausted. So that also dampens the uncertainty. Where there is, I think for us, the most uncertainty is the treatment of the interpretation of the loss in terms of the number of events and how it's reported by our reinsurers into the reinsurance and retrocessional market. So those are the biggest drivers of the uncertainty. Faramarz, do you want any color to that or is that pretty much?

No. I think, you know, we've always reserved at our best estimate as Greg said. And, you know, it's hard to tell exactly how much the ultimate settlements will be. You know, as reinsurers, we're one layer removed and there's been a lot of settlements happening on the underlying business, but, you know, there could be various movements on it. The one thing we haven't received are formal notices or formal notification from our seasons on the losses. So, you know, at this point, all of the reserve that we booked and, you know, previously in 2022 as well as the increase this quarter is booked as IBNR. So we are anticipating there's going to be claims now starting to flow in from what we're hearing in the industry. So we've taken the strengthening this quarter in anticipation of that.

Does that answer that any?

Yeah. Yeah. It does. Thank you for the full answer on that. If I may, I have a second question. Specifically, I was thinking about the other adverse development trends you cited in the quarter. It sounds specific to casualty books. I was curious, you know, if there are any primary accident years or specific books of businesses impacted by inflationary or other accelerating trends, just anything you can share there?

Yeah. These are secondary and smaller issues relative to the Ukraine adverse development. We continue to observe, you know, the development in casualty lines. Our historical exposure to sort of the broader market casualty trends are primarily from earlier years from a large retrocessional contract that we wrote. Fortunately, that contract was started to shrink before the market started getting particularly bad. I think our biggest exposure is maybe the fifteen, sixteen, seventeen years, but then diminishing for eighteen and nineteen. So in terms of that wholesale open market, you know, casualty reinsurance adverse development, that's fairly older. We think that we have that pretty well boxed in, but, you know, we can't guarantee that, but it's not huge. We don't think. I think our go-forward book tends to be smaller limits, more frequency severity, not the major casualty programs that are subject to nuclear verdicts and aggressive plaintiff attorneys and severity kind of problems that have been plaguing the industry. So that's, you know, we have seen some adverse development in the casualty lines. It's not something that we think is hugely problematic for us. Does that fair answer?

Yeah. You know, there's some of the legacy casualty contracts what's impacting it. We did in the quarter have favorable development on our special lines as well. So when you look at our overall adverse development for the quarter, you know, Ukraine was by far the largest. We had some adverse on casualty, which was for the most part offset by favorable development on our specialty book.

Okay. Thank you. And as I think about sort of this go-forward book, you know, you shared an update about one-one renewals for property on specialty. How are you thinking about where does casualty fit into the growth profile today? Are there areas specific lines of business that you find attractive now, or is there still just caution given the loss environment here?

Yeah. I think caution. You know, as an underwriting team, we're very much underwriting margin focus. And so casualty today I think is being underwritten with an eye to future investment income. I think there's a role of ILS that's playing in this that allows people to monetize future investment income in the forms of ceding commissions. I think that major we're not likely to be a major player on the large US national casualty programs. But where we are attracted is some of these smaller programs, and we definitely don't want to turn off the spigot on that area. There's a lot going on there. I think some of the major markets, some of the in the reinsurance industry, are being cautious in that area and maybe even pulling back that can also create opportunities in casualties. So I don't want to paint a completely negative picture about casualty, but we want to be sort of strategic and targeted where we, Greenlight Capital Re, Ltd., as a smaller company, can compete most effectively. And I think some of that, for example, is in our innovation space.

Well, thank you for your time and for all the answers today.

Okay. Any other questions? Yeah. Thank you. Our next question is coming from Eric Hogan from BTIG. Your line is now live.

Hey, thanks. Good morning. Good to hear from you guys. Thanks for a great investor day back in November. I want to revisit the overall capital allocation, how you see the target allocation maybe changing with the chunk of the business renewing over the next, you know, the near to medium term? And does the broader market volatility right now actually serve as an opportunistic window to deviate from the capital allocation strategy overall? You know, at all here. Thank you.

Yeah. I think it's incremental, not a step change. As we said at investor day, we continue to find the returns on our Silpe investment strategy very attractive. And so over time, you know, continuing with that allocation, possibly increasing allocation, is something that is accretive to us as we indicated on Investor Day. Open market is subject to cyclical pressures in the overall global reinsurance market. So we did see softening, modest softening, maybe a little more than we expected though at investor day. I don't think the rates remain very attractive, so, you know, as you see, we grew that segment at one-one. But if rates continue to soften and all indications are that they will in 2026 and beyond, absent major market-changing events, then we would begin probably to reallocate capital from that, perhaps increase our outward purchases is one way to manage that capital allocation down. And what do we do? Either could allocate that capital to innovations, to other pillars, or buyback shares. But that's more of a 2026 and beyond kind of a question. Innovations again, we find that attractive. We see that as a great growth opportunity building on some really distinctive strengths that Greenlight Capital Re, Ltd. has in that area. And I'm committed to finding ways to leverage those strengths. So that's an area we would look for growth over time.

And, Eric, the only thing I would add, this is Faramarz, is that, you know, on the innovation side, we did enter into a whole account quota share in Q4, which was, you know, a way of allocating capital and allowing for more growth in that segment by freeing up some capital by having that retro program in place as well.

Yep. Okay. This is helpful. Thank you, guys. On the MicroStrategy arbitrage, is there a target rate of return you're looking for on an opportunistic trade like that? How does it compare to the target return you might look for in other pair of trades or opportunities you apply in Solus Glass?

Yeah. This is David. Thanks for the question. I don't think there's a way to calculate a target rate of return for the arbitrage. There's two dynamics that work for it. One is that the double-levered ETFs relating to MicroStrategy achieve some of their leverage through high volatility, very expensive call options. And as those call options decay or have to get rolled on a continued basis, there's just a drain in NAV that investors who own these things don't seem to appreciate. And then secondarily, there's the impact of the negative gamma that is created through the double leverage such that on up days, they have to buy more, and on down days, they have to sell more. So to the extent you have chop, the gamma, you know, kind of destroys the return. The return on that position since we put it on has been exceedingly high. It probably annualizes nearly triple digits. So it's a lot better than many other things that we've been able to do.

Great stuff. Appreciate you guys. Thank you.

Thank you. There are no further questions at this time. Should you have any follow-up questions, please direct them to Karen Daly of the Equity Group Inc. at IR at GreenlightRe.ky, and she'll be happy to assist you. This now concludes Greenlight Capital Re, Ltd.'s fourth quarter and year-end 2024 earnings conference call. Thank you. You may now disconnect.